advertisement

---

Januleviciene I 8

Showing records 1 to 8 | Display all abstracts from Januleviciene I

118782 A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model
Maciulaitiene R
PLoS ONE 2024; 19: e0308671

---

117151 Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial
Muñoz-Negrete FJ; Topouzis F
Journal of Glaucoma 2024; 33: 422-430

---

118782 A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model
Kalesnykas G
PLoS ONE 2024; 19: e0308671

---

117151 Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial
Oddone F
Journal of Glaucoma 2024; 33: 422-430

---

118782 A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model
Pauza DH
PLoS ONE 2024; 19: e0308671

---

117151 Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial
Nisslé S
Journal of Glaucoma 2024; 33: 422-430

---

118782 A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model
Januleviciene I
PLoS ONE 2024; 19: e0308671

---

117151 Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial
Rokicki D; Januleviciene I; Harasymowycz P; Stalmans I
Journal of Glaucoma 2024; 33: 422-430

---